Back
RespireRx Pharmaceuticals, Inc. 10K Form
Buy
61
RSPI
RespireRx Pharmaceuticals, Inc.
Last Price:
$0.0018
Seasonality Move:
-0.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-11-23 | 10Q | RSPI/RespireRx Pharmaceuticals, Inc. Quarterly |
| 2020-08-19 | 10Q | RSPI/RespireRx Pharmaceuticals, Inc. Quarterly |
| 2020-05-20 | 10Q | RSPI/RespireRx Pharmaceuticals, Inc. Quarterly |
| 2020-04-14 | 10K | RSPI/RespireRx Pharmaceuticals, Inc. Annual |
| 2019-11-19 | 10Q | RSPI/RespireRx Pharmaceuticals, Inc. Quarterly |
| 2019-08-14 | 10Q | RSPI/RespireRx Pharmaceuticals, Inc. Quarterly |
Receive RSPI News And Ratings
See the #1 stock for the next 7 days that we like better than RSPI
RSPI Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
RespireRx Pharmaceuticals, Inc. Earnings Forecast
Key RespireRx Pharmaceuticals, Inc. Financial Ratios
-
Per Share Earnings over the last 34 years have been positive in 18 years.
RespireRx Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RSPI |
| Website: | respirerx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RSPI Technical Analysis vs Fundamental Analysis
Buy
61
RespireRx Pharmaceuticals, Inc. (RSPI)
is a Buy
Is RespireRx Pharmaceuticals, Inc. a Buy or a Sell?
-
RespireRx Pharmaceuticals, Inc. stock is rated a BuyThe current RespireRx Pharmaceuticals, Inc. [RSPI] share price is $0.0018. The Score for RSPI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.